These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


367 related items for PubMed ID: 11103751

  • 1. The cytochrome P450 3A4 inhibitor itraconazole markedly increases the plasma concentrations of dexamethasone and enhances its adrenal-suppressant effect.
    Varis T, Kivistö KT, Backman JT, Neuvonen PJ.
    Clin Pharmacol Ther; 2000 Nov; 68(5):487-94. PubMed ID: 11103751
    [Abstract] [Full Text] [Related]

  • 2. Diltiazem and mibefradil increase the plasma concentrations and greatly enhance the adrenal-suppressant effect of oral methylprednisolone.
    Varis T, Backman JT, Kivistö KT, Neuvonen PJ.
    Clin Pharmacol Ther; 2000 Mar; 67(3):215-21. PubMed ID: 10741623
    [Abstract] [Full Text] [Related]

  • 3. Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics of pioglitazone.
    Jaakkola T, Backman JT, Neuvonen M, Neuvonen PJ.
    Clin Pharmacol Ther; 2005 May; 77(5):404-14. PubMed ID: 15900286
    [Abstract] [Full Text] [Related]

  • 4. Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid.
    Neuvonen PJ, Jalava KM.
    Clin Pharmacol Ther; 1996 Jul; 60(1):54-61. PubMed ID: 8689812
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Itraconazole greatly increases plasma concentrations and effects of felodipine.
    Jalava KM, Olkkola KT, Neuvonen PJ.
    Clin Pharmacol Ther; 1997 Apr; 61(4):410-5. PubMed ID: 9129558
    [Abstract] [Full Text] [Related]

  • 7. Plasma concentrations and effects of oral methylprednisolone are considerably increased by itraconazole.
    Varis T, Kaukonen KM, Kivistö KT, Neuvonen PJ.
    Clin Pharmacol Ther; 1998 Oct; 64(4):363-8. PubMed ID: 9797792
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of itraconazole on pharmacokinetics of paroxetine: the role of gut transporters.
    Yasui-Furukori N, Saito M, Niioka T, Inoue Y, Sato Y, Kaneko S.
    Ther Drug Monit; 2007 Feb; 29(1):45-8. PubMed ID: 17304149
    [Abstract] [Full Text] [Related]

  • 10. The effect of ingestion time interval on the interaction between itraconazole and triazolam.
    Neuvonen PJ, Varhe A, Olkkola KT.
    Clin Pharmacol Ther; 1996 Sep; 60(3):326-31. PubMed ID: 8841155
    [Abstract] [Full Text] [Related]

  • 11. Voriconazole, but not terbinafine, markedly reduces alfentanil clearance and prolongs its half-life.
    Saari TI, Laine K, Leino K, Valtonen M, Neuvonen PJ, Olkkola KT.
    Clin Pharmacol Ther; 2006 Nov; 80(5):502-8. PubMed ID: 17112806
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Itraconazole decreases the clearance and enhances the effects of intravenously administered methylprednisolone in healthy volunteers.
    Varis T, Kivistö KT, Backman JT, Neuvonen PJ.
    Pharmacol Toxicol; 1999 Jul; 85(1):29-32. PubMed ID: 10426160
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of fluconazole and fluvoxamine on the pharmacokinetics and pharmacodynamics of glimepiride.
    Niemi M, Backman JT, Neuvonen M, Laitila J, Neuvonen PJ, Kivistö KT.
    Clin Pharmacol Ther; 2001 Apr; 69(4):194-200. PubMed ID: 11309547
    [Abstract] [Full Text] [Related]

  • 19. Plasma concentrations of inhaled budesonide and its effects on plasma cortisol are increased by the cytochrome P4503A4 inhibitor itraconazole.
    Raaska K, Niemi M, Neuvonen M, Neuvonen PJ, Kivistö KT.
    Clin Pharmacol Ther; 2002 Oct; 72(4):362-9. PubMed ID: 12386638
    [Abstract] [Full Text] [Related]

  • 20. Ketoconazole inhibits the clearance of the enantiomers of the antidepressant reboxetine in humans.
    Herman BD, Fleishaker JC, Brown MT.
    Clin Pharmacol Ther; 1999 Oct; 66(4):374-9. PubMed ID: 10546921
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.